Literature DB >> 13783427

Host-parasite factors in group A streptococcal infections. Pyrogenic and other effects of immunologic distinct exotoxins related to scarlet fever toxins.

D W WATSON.   

Abstract

The factors present in streptococcal lesion extracts (SLE) which enhanced the lethal and tissue-damaging properties of Gram-negative bacterial endotoxins and streptolysin O were identified with the scarlet fever group of toxins. Toxic manifestations attributed to this group of toxins included lethality, cardiotoxic and other tissue damage, enhancement of toxicity, and pyrogenicity. Of these, the measurement of febrile response in American Dutch rabbits was the most useful parameter of toxicity. In rabbits, repeated daily intravenous injections of 0.125 Lf of a purified erythrogenic toxin immunizes specifically against the pyrogenic activity; this technique was used to type the toxins and to distinguish them from exogenous and endogenous pyrogens; non-specific pyrogens, such as streptococcal endotoxin, were not found in SLE. All types of the Lancefield Group A streptococci tested produced one or or more immunologically distinct toxins in vivo in contrast to Groups B and C which did not produce them; toxins A and B, previously distinguished by neutralization of rash-inducing activity in the skin, were produced in vivo. The A toxin was the most common, as indicated by its presence in extracts prepared with Types 28, 12, 17, and 10 (NY-5); B toxin was found in 10 (NY-5) and 19. A new toxin, designated C, was obtained from a Type 18. In American Dutch rabbits, purified toxin at a concentration of 15 Lf (900,000 STD) neither gave a Dick test nor prepared the skin for the local Shwartzman reaction; by this route, however, in contrast to classical endotoxins, they enhance the lethal and tissue-damaging properties of sublethal doses of these and other toxins. These properties of the immunologic distinct exotoxins as demonstrated in American Dutch rabbits suggest by analogy their importance in the pathogenesis of streptococcal disease in man. Evidence that might implicate them in sequelae, in addition to scarlet fever, is discussed.

Entities:  

Keywords:  STREPTOCOCCAL INFECTIONS/immunology

Mesh:

Substances:

Year:  1960        PMID: 13783427      PMCID: PMC2137249          DOI: 10.1084/jem.111.2.255

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  25 in total

1.  Further studies of group A streptococcal factors with lethal and cardiotoxic properties.

Authors:  J H SCHWAB; D W WATSON; W J CROMARTIE
Journal:  J Infect Dis       Date:  1955 Jan-Feb       Impact factor: 5.226

2.  The use of bacteria grown in vivo for studies on the basis of their pathogenicity.

Authors:  H SMITH
Journal:  Annu Rev Microbiol       Date:  1958       Impact factor: 15.500

3.  Production of generalized Shwartzman reaction with group A streptococcal factors.

Authors:  J H SCHWAB; D W WATSON; W J CROMARTIE
Journal:  Proc Soc Exp Biol Med       Date:  1953-04

4.  Neurospora diphosphopyridine nucleotidase.

Authors:  N O KAPLAN; S P COLOWICK; A NASON
Journal:  J Biol Chem       Date:  1951-08       Impact factor: 5.157

5.  The differentiation of three distinct desoxyrlbonucleases of group A Streptococci.

Authors:  L W WANNAMAKER
Journal:  J Exp Med       Date:  1958-06-01       Impact factor: 14.307

6.  TOLERANCE TO BACTERIAL PYROGENS : I. FACTORS INFLUENCING ITS DEVELOPMENT.

Authors:  P B Beeson
Journal:  J Exp Med       Date:  1947-06-30       Impact factor: 14.307

7.  A QUANTITATIVE STUDY OF THE SCARLET FEVER TOXIN-ANTITOXIN FLOCCULATION REACTION.

Authors:  G A Hottle; A M Pappenheimer
Journal:  J Exp Med       Date:  1941-11-30       Impact factor: 14.307

8.  Studies on the pathogenesis of fever. II. Characterization of fever-producing substances from polymorphonuclear leukocytes and from the fluid of sterile exudates.

Authors:  I L BENNETT; P B BEESON
Journal:  J Exp Med       Date:  1953-11       Impact factor: 14.307

9.  Studies on the pathogenesis of fever. I. The presence of transferable pyrogen in the blood stream following the injection of typhoid vaccine.

Authors:  E ATKINS; W B WOOD
Journal:  J Exp Med       Date:  1955-05-01       Impact factor: 14.307

10.  THE CARDIOTOXIC ACTION OF PREPARATIONS CONTAINING THE OXYGEN-LABILE HEMOLYSIN OF STREPTOCOCCUS PYOGENES : I. INCREASED SENSITIVITY OF THE ISOLATED FROG'S HEART TO REPEATED APPLICATION OF THE TOXIN.

Authors:  A W Bernheimer; G L Cantoni
Journal:  J Exp Med       Date:  1945-03-01       Impact factor: 14.307

View more
  60 in total

1.  Pyrogenicity and cytokine-inducing properties of Streptococcus pyogenes superantigens: comparative study of streptococcal mitogenic exotoxin Z and pyrogenic exotoxin A.

Authors:  H Müller-Alouf; T Proft; T M Zollner; D Gerlach; E Champagne; P Desreumaux; C Fitting; C Geoffroy-Fauvet; J E Alouf; J M Cavaillon
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

2.  Residues 20, 22, and 26 determine the subtype specificities of staphylococcal enterotoxins C1 and C2.

Authors:  T N Turner; C L Smith; G A Bohach
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

3.  Relative abilities of distinct isotypes of human major histocompatibility complex class II molecules to bind streptococcal pyrogenic exotoxin types A and B.

Authors:  K Imanishi; H Igarashi; T Uchiyama
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

4.  SURGERY AND MICROBIOLOGY.

Authors:  C LYONS
Journal:  Ann Surg       Date:  1963-11       Impact factor: 12.969

5.  THE PYROGENIC EFFECT OF SCARLET FEVER TOXIN. I. NEUTRALIZATION WITH ANTITOXIN; THE NATURE OF TOLERANCE.

Authors:  V SCHUH
Journal:  Folia Microbiol (Praha)       Date:  1965-05       Impact factor: 2.099

6.  Reinterpretation of the Dick test: role of group A streptococcal pyrogenic exotoxin.

Authors:  P M Schlievert; K M Bettin; D W Watson
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

7.  Molecular characterization of new group A streptococcal bacteriophages containing the gene for streptococcal erythrogenic toxin A (speA).

Authors:  C E Yu; J J Ferretti
Journal:  Mol Gen Genet       Date:  1991-12

8.  The gene for type A streptococcal exotoxin (erythrogenic toxin) is located in bacteriophage T12.

Authors:  C R Weeks; J J Ferretti
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

9.  Purification and physicochemical and biological characterization of a staphylococcal pyrogenic exotoxin.

Authors:  P M Schlievert; D J Schoettle; D W Watson
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

10.  Superantigenic properties of the group A streptococcal exotoxin SpeF (MF).

Authors:  A Norrby-Teglund; D Newton; M Kotb; S E Holm; M Norgren
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.